VYXEOS liposomal subst sèche 44/100 mg flac
7680680140017
CH-68014
L01XY01
07.16.1.
1 / 2
google
Details
- Product number
- 6801401
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- cytarabinum 100 mg, daunorubicinum 44 mg, distearoylphosphatidylcholinum, distearoylphosphatidylglycerolum natricum, cholesterolum, cupri(II) d-gluconas, trolaminum, saccharum, pro vitro.
Articles (1)
Vyxeos liposomal 44 mg/100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionsdispersion
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
44.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Jazz Pharmaceuticals
6300 Zug
Authorization information
- Swissmedic authorization number
- 68014
- Drug name
- Vyxeos liposomal, Pulver für ein Konzentrat zur Herstellung einer Infusionsdispersion
- Galenic form
- PULPD
- ATC Code
- L01XY01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 17/02/2022
- Authorization expiration date
- 16/02/2027
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VYXEOS liposomal subst sèche 44/100 mg flac
- Description (DE)
- VYXEOS liposomal Trockensub 44/100 mg Durchstf
- Market launch
- 17/02/2022
- Narcotic (BTM)
- No